Actinium Pharmaceuticals Inc (ATNM) stock news · rev $90.0K
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
This ATNM news page leads with what Actinium Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ATNM yet. We will not pad this page with generic market recap.
Latest reported ATNM revenue for 2025-12-31 was $90.0K. Net income was -$33.9M. Revenue was up 11.1% from 2023-12-31 to 2025-12-31. ATNM currently screens at market cap $33.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ATNM stock page; for the tape open the quote page.
ATNM stock news FAQ
What are ATNM's latest revenue and net income?
Latest cached Actinium Pharmaceuticals Inc (ATNM) revenue for Dec 31, 2025 was $90.0K. Net income was -$33.9M. Statements: https://lician.com/financials/atnm
How did ATNM revenue change from the prior cached period?
Cached Actinium Pharmaceuticals Inc (ATNM) revenue was up 11.1% from $81.0K (Dec 31, 2023) to $90.0K (Dec 31, 2025). Statements: https://lician.com/financials/atnm
What is ATNM's market cap?
Actinium Pharmaceuticals Inc (ATNM) market cap is $33.9M on the latest cached fundamentals snapshot.
What kind of company is ATNM?
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Where is ATNM stock news listed?
Cached stock news for Actinium Pharmaceuticals Inc (ATNM) is listed at https://lician.com/news/atnm. Filings: https://lician.com/sec/atnm
Not investment advice.